Amanda DeSimone-Shabrack relies on a home healthcare aide to help her high-needs autistic 12-year-old son. Virginia’s Medicaid program covers the assistance, enabling her to work as both an education technology specialist and a professor, run errands, and keep Mason in the home. That could change. In June, the Department of Justice issued a legal opinion…
More than a dozen health systems are warning patients of a phishing campaign impersonating Epic’s MyChart portal with fake Medicare rewards and faux login pages. Experts say the scam exposes a deeper problem: patients can’t be expected to spot increasingly polished fakes, so the responsibility falls on providers to communicate in ways that build trust….
There was an increase in life expectancy between 2021 and 2023 across all racial and ethnic groups. American Indian and Alaska Native (AIAN) people experienced the largest increase in life expectancy of 4.5 years during this time, followed by Hispanic (3.5 years) and Black people (2.8 years).
Twelve health systems are coming together with Aidoc to co-design AI-enabled diagnostic workflows and measure their impact on safety, quality and speed to diagnosis
Abbott’s $23 billion acquisition of Exact Sciences positions the company to become a major player in cancer diagnostics. Experts think the deal makes strategic sense, as it offers higher margins and a broader commercial scale — but questions remain about long-term growth amid rising competition and the challenges of integrating a patient-focused, tech-heavy business. The…
Right to repair would undermine the FDA’s regulations and introduce unnecessary risk into the healthcare industry, threatening the high-quality care that doctors provide patients. The post Don’t Erode Medical Device Trust with Right to Repair appeared first on MedCity News.
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Day One Biopharmaceuticals is Servier’s biggest acquisition yet, topping the $2.4 billion it paid to buy Shire’s cancer business in 2018. Day One markets Ojemda, approved for treating pediatric low-grade glioma, the most common type of brain cancer in children. The post Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma…
The share of people who are Hispanic or Latino has grown to a little more than a quarter of the population in Elko, Nevada, a small city in the remote northeastern corner of the state. That growth in diversity has also led to an increasing number of people who speak a language other than English…
That is the question Luis Garicano asks in his recent post. He relies on projections from the 2025 IMF World Economic Outlook. On the positive side, Eastern European countries’ economies are likely to converge with the US. While we have spent a decade complaining about Europe’s stagnation, a real positive convergence story has been unfolding…